Best Life Sciences Platforms and Tools Companies in Los Angeles, United States
The 39 best Life Sciences Platforms and Tools companies in Los Angeles, United States in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: Trethera.
Our analysis of 50 Life Sciences Platforms and Tools companies
$4.8b in tracked funding; 68% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2025.
Ranked: Best Life Sciences Platforms and Tools companies in Los Angeles
| # | Company | Disclosed funding | Last round | Stage | Employees | Founder | Tech stack | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Trethera Developer of small molecule cancer therapeutics that target DNA replication and integrity 29Funding top 30%Patents top 37%Moat top 37%Product top 41% All 9 signals ▾Fundingtop 30% Patentstop 37% Moattop 37% Producttop 41% Innovationtop 42% Techtop 47% Talentbottom 49% Globalbottom 33% Marketbottom 18% Funding: Raised $31.0M across 20 rounds · 20 rounds over 11 yrs (1.8/yr) Patents: 15 patents matched (strict assignee match) · 15 filings since 2022 vs 0 in 2017-21 rank vs industry peers · Fliar Intelligence Index 29/100 | $31M | 11 mo ago | Series C | 3 | Ken Schultz Chairman & CEO | WordPressMySQLPHP+16 | 15 patents Solid-state pharmaceutical forms of deoxycytidine kinase inhibitor drugs | — |
| 2 | CBR Provides services for cord blood and cord tissue stem cells preservation | $18M | 97 mo ago | Acquired | 227 | — | ContentfulApple iCloud MailNode.js+32 | — | — |
| 3 | Partillion Developer of single-cell assays for cell analysis | $10M | 17 mo ago | Seed | 6 | — | — | — | 2 launchs |
| 4 | Forcyte Biotechnologies Developer of automated single-cell contractility screening system for drug discovery | $6M | 51 mo ago | Seed | 7 | Ivan Pushkarsky Co-Founder & President | — | — | — |
| 5 | Ferrologix Developer of magnetic based instrument for cell sorting | $5M | 43 mo ago | Funding Raised | 4 | Dino Di Carlo Co-Founder | — | 4 patents Magnetic particle separation for industrial and biomedical applications | — |
| 6 | Nesher Technologies Nano-biotechnology solutions for research and diagnostics | $4M | 133 mo ago | Funding Raised | — | Armin Reitmair CEO | — | 2 patents Highly sensitive multiplexed microRNA detection for biomarker diagnostics | — |
| 7 | DxTerity Provider of a direct-to-consumer, non-clinical genetic tests | $4M | 140 mo ago | Series A | 37 | Bob Terbrueggen President and CEO | — | — | — |
| 8 | Molecular Instruments Provider and developer of molecular instruments for drug development | $2M | 24 mo ago | Funding Raised | 28 | — | Cart FunctionalityWixSentry+11 | — | 2 launchs |
| 9 | Maven Biotech Develops label free internal reflection ellipsometry analysis systems | $2M | 191 mo ago | Funding Raised | — | William Rassman Founder & CEO | — | — | — |
| 10 | SeqOnce Biosciences Provider of products & services for DNA and RNA Next Generation Sequencing sample preparation | $2M | 22 mo ago | Seed | 17 | — | — | — | — |
| 11 | Intan Technologies Miniaturized electrophysiology solutions: microchips, headstages, software, and systems for neural research | $2M | 136 mo ago | Funding Raised | — | Reid Harrison Founder | LiteSpeedGoogle Font APIMailChimp+2 | — | — |
| 12 | Omega Biosystems Incorporated High throughput imaging flow cytometer | $1M | 121 mo ago | Deadpooled | — | Eric Diebold Founder & President | — | 14 patents Advanced multi-modal fluorescence imaging flow cytometry for high‑throughput cellular analysis | — |
| 13 | Lucendi AI-enabled smart measurement systems using computational microscopy technology for micro-object… | $1M | 10 mo ago | Series A | 5 | Aydogan Ozcan Co-Founder | — | — | — |
| 14 | Branchpoint Biosciences Developer of qPCR-based microbiome profiling assays and services | $409K | 25 mo ago | Funding Raised | — | Steven Finkel Co-Founder | — | — | — |
| 15 | EntroGen Molecular diagnostic solutions for oncology, hematology, automation, reagents, and software | $286K | 157 mo ago | Funding Raised | 20 | — | WordPressMySQLPHP+23 | — | — |
| 16 | Dalton Bioanalytics Provider of bioanalytical services for molecular analysis | $250K | 82 mo ago | Seed | 4 | Austin Quach Co-Founder & Cso | — | — | — |
Top 12 Life Sciences Platforms and Tools companies in Los Angeles
#1
Series C · Los Angeles, California · founded 2013 · 3 employees$31Mraised▾
Developer of small molecule cancer therapeutics that target DNA replication and integrity. Its lead compounds target metabolic pathways that control DNA replication and signal transduction pathways that allow cells to repair DNA damage. Its lead candidate is a deoxycytidine kinase inhibitor that is currently under investigation for leukemia and solid tumors.
- Sep 2025Grant (prize money)$1.8M
- Sep 2025Grant (prize money)$610.9K
- Aug 2025Grant (prize money)$2M
- Aug 2025Grant (prize money)$995K
#2
Seed · Los Angeles, California · founded 2020 · 6 employees$9.9Mraised▾
Developer of single-cell assays for cell analysis. The company has a nanovial platform to advance single-cell assays and the rapid compartmentalization and analysis of millions of single cells to probe biological functions such as secreted proteins.
- Apr 2025Grant (prize money)$1M
- Sep 2023Seed$5M
- Sep 2023Grant (prize money)$1.5M
- Aug 2023Grant (prize money)$275.5K
#3
Series A · Los Angeles, California · founded 2016 · 5 employees$1Mraised▾
AI-enabled smart measurement systems using computational microscopy technology for micro-object characterization. The company's flagship product is Aqusens, an imaging flow cytometry platform that consists of an innovative computational microscopy sensing system fused with big data analytics platform capable of expedient image analysis.
- Oct 2025Series A$1M
- Sep 2023Seed$1M
- Jul 2019Grant (prize money)$1.3M
- Feb 2019Grant (prize money)$224.9K
#4
Seed · Los Angeles, California · founded 2014 · 17 employees$1.9Mraised▾
SeqOnce Biosciences is developing technologies and providing products & services for DNA and RNA Next Generation Sequencing sample preparation. Its products include kits for next generation sample preparation including ProntoSeq- a suite of Library Preparation kits for Illumina NGS Platforms; Pronto-Seq- Rapid DNA-seq Kits (WGS, ChIP-seq, Bisulfite-seq); Pronto-Seq- Library Prep Kits (mid-2017) (Single Cell WGA, cDNA, PCR-Free WGS). The company also provides NGS sample preparation service using its novel sample preparation technology.
- Oct 2024Seed$881.8K
- Oct 2018Seed—
- Apr 2018Seed$1M
#5
Funding Raised · Los Angeles, California · founded 2018 · 28 employees$2.1Mraised▾
Provider and developer of molecular instruments for drug development. The company has designed a molecular hybridization instrument that assists academic researchers with, drug development and clinical diagnosis. The device has features for a hybridization chain reaction, qHCR Imaging, flow cytometry, northern blots, and more.
- Sep 2024Grant (prize money)$905.9K
- Apr 2021Grant (prize money)$1.1M
#6
Funding Raised · Los Angeles, California · founded 2015 · 4 employees$5.2Mraised▾
Developer of magnetic based instrument for cell sorting. The company is focused on developing a suite of bioprocessing platforms called Digital Magnetic Sorting, enables quantitative cell sorting based on each cell's magnetic intensity, allowing for the isolation of rare cell types and multiple populations.
- Feb 2023Grant (prize money)$2M
- Sep 2020Grant (prize money)$2.2M
- Sep 2019Grant (prize money)$225K
- Aug 2019Grant (prize money)$323.6K
#7
Seed · Los Angeles, California · founded 2017 · 7 employees$5.7Mraised▾
Developer of automated single-cell contractility screening system for drug discovery. Their technology provides direct access to cellular force generation at the single-cell level. The company is focusing on therapeutic areas including migraine, fibrosis, urology, reproductive, respiratory, cardiovascular, & oncology. The company was awarded NIH funding for a FLECS-based migraine model.
- Jun 2022Seed—
- Sep 2021Grant (prize money)$350K
- Jul 2021Grant (prize money)$394.1K
- 2021Seed$125K
#8
Funding Raised · Los Angeles, California · founded 2023$409.4Kraised▾
Developer of qPCR-based microbiome profiling assays and services. It offers species-specific assays for quantitative microbial detection, compatible with various real-time PCR machines. Custom assay design is also available, tailored to specific phylogenetic resolution needs. The company develops quantitative microbiome profiling products for various body sites, providing straightforward taxonomic profiles without requiring extensive bioinformatics. These products aim to simplify microbiome analysis for researchers and clinicians.
- Aug 2024Grant (prize money)$409.4K
#9
Acquired · Los Angeles, California · founded 1992 · 227 employees$18Mraised▾
Cord Blood Registry (CBR) provides services for stem cell collection and storage. It is dedicated to advancing the clinical application of newborn stem cells by partnering with leading research institutions to establish FDA-regulated clinical trials, requiring CBR processed cord blood, for conditions, which is an AABB accredited, ISO certified, FDA registered, and has a state-of-the-art storage facility.
- Aug 2018Conventional Debt—
- Oct 2012Series B—
- Oct 2002Series A$18M
- 2001Series A—
#10
Funding Raised · Los Angeles, California · founded 2004$3.8Mraised▾
Nesher Technologies is a nano-biotech company established to commercialize an ultrasensitive bio-detection technology developed at the UCLA Single Molecule Biophysics laboratory. The technology is based on Alternating Laser EXcitation (ALEX) single molecule fluorescence spectroscopy for ultrasensitive, specific, and highly multiplexed detection and quantification of target molecules such as proteins, RNAs (including microRNAs), and DNAs in complex samples. The company intends to use the technology to develop solutions for basic research and drug discovery, biomarker validation and translational research, and in vitro diagnostics.
- Aug 2015Grant (prize money)$150K
- Apr 2014Grant (prize money)$321.1K
- Sep 2013Grant (prize money)$462.7K
- Sep 2012Grant (prize money)$119.5K
#11
Series A · Los Angeles, California · founded 2006 · 37 employees$3.6Mraised▾
Provider of direct-to-consumer, non-clinical genetic tests. It uses RT-PCR and DxTerity's proprietary DxDirect chemistry for the development of assay, DxDirect, a technique for analysis of gene signatures that combines chemical ligation process, NEAT, and sample stabilization system, DxCollect. Using DxTerity's genomics platform, fingerstick blood can be safely collected and shipped to DxTerity via US mail for non-clinical analysis.
- Dec 2014Series A$100K
- Feb 2012Series A$2.6M
- Sep 2011Grant (prize money)$167K
- Sep 2011Grant (prize money)$167K
#12
Deadpooled · Los Angeles, California · founded 2014$1.5Mraised▾
Omega Biosystems is engaged in the development and commercialization a high throughput imaging flow cytometer for application in pharma and diagnostic industry. The company claims that their image-based cell fluorescence flow cytometer along with novel signal processing algorithms will allow separation of cells based on measurement of the nuclear to cytoplasmic area ratio. The flow cytometer seems to be a promising tool for advancement in the field of drug discovery and rare cell detection.
- Aug 2016Grant (prize money)$66.2K
- Apr 2016Grant (prize money)$750K
- Jan 2015Grant (prize money)$500.3K
- Jan 2015Grant (prize money)$150K
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Life Sciences Platforms and Tools coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
How research on Bioinformatics is moving in the United States
A read on the academic research around Bioinformatics — which themes are gaining ground, the institutions and researchers driving them, and how the tone is shifting. Based on 13,110 United States-affiliated papers.
- Harvard University633
- Broad Institute433
- Howard Hughes Medical Institute318
- Stanford University287
- Johns Hopkins University287
- Gene83→532
- Transcriptome25→436
- Genome117→419
- Disease6→218
- Immune system11→219
- Disease17→407
- Immune system4→266
- Gene38→281
- Transcriptome13→238
- Biomarker2→208
- Disease27→311
- Immune system6→152
- Cancer17→130
- Clinical trial4→111
- Biomarker2→92
Where bioinformatics is researched across United States
Location clusters by institution affiliation — each city's volume, stance tone, and a quick read on its hot topic, what's advancing, the opening opportunity, and the main concern.
Who's filing bioinformatics patents in the United States
United States bioinformatics patent filing is accelerating — 246 filings from 64 assignees (2016–2025), led by Edico Genome, Illumina, UNIV Washington; annual filings 22→23.
- Edico Genome129
- Illumina60
- UNIV Washington18
- Nantomics9
- Baluch Mohamed Khoso7
- Genomsys7
- Microsoft6
- Contamination Source Identificat5
Common questions
Rohit lives in the feed. He covers what's moving right now — the funding rounds, launches and shifts breaking across the trade press — and ties them back to where the sector is heading.